Gong Xue, Xu Yan, Ren Kai, Bai Xiaorong, Zhang Chunhong, Li Minhui
Department of Pharmacy, Baotou Medical College, Baotou, China.
Department of Emergency, The First Affiliated Hospital of Baotou Medical College of Inner Mongolia University of Science and Technology, Baotou, China.
Biosci Biotechnol Biochem. 2019 Dec;83(12):2202-2212. doi: 10.1080/09168451.2019.1654359. Epub 2019 Aug 14.
In this study, we isolated eight phenylethanoid glycosides from for the first time, and evaluated the mechanism underlying their neuroprotective effects against HO-induced injury in PC12 cells. The MTS method was utilized to screen the phenylethanoid glycosides for protective ability. Next, qRT-PCR and western blotting analysis were used to detect the transcription levels of HO-1 and GCLC, which are regulated by Nrf2. The inhibitor ZnPP was used to analyze the involvement of Nrf2 in HO-1 expression. Analyses showed that caleolarioside B, paraboside B, and paraboside II also upregulated the expression of HO-1, but showed no obvious effect on GCLC. Pretreatment with ZnPP significantly reduced the neuroprotective effects. Thus, phenylethanoid glycosides isolated from protected PC12 cells from HO-induced damage by upregulating HO-1. The results provided evidence that might be a potential therapeutic agent for the treatment of neurodegenerative diseases.
在本研究中,我们首次从[具体来源未提及]中分离出8种苯乙醇苷,并评估了它们对PC12细胞中HO诱导损伤的神经保护作用机制。采用MTS法筛选具有保护能力的苯乙醇苷。接下来,使用qRT-PCR和蛋白质印迹分析来检测受Nrf2调控的HO-1和GCLC的转录水平。使用抑制剂ZnPP来分析Nrf2在HO-1表达中的作用。分析表明,caleolarioside B、paraboside B和paraboside II也上调了HO-1的表达,但对GCLC没有明显影响。用ZnPP预处理显著降低了神经保护作用。因此,从[具体来源未提及]中分离出的苯乙醇苷通过上调HO-1保护PC12细胞免受HO诱导的损伤。结果提供了证据表明[具体来源未提及]可能是治疗神经退行性疾病的潜在治疗剂。